Annovis Bio announces special shareholder meeting
ANVS•Equity plan amendment and adjournment proposal
Investors will vote to ratify an amended 2019 equity incentive plan, lifting the share reserve to 5,500,000.
A separate proposal seeks approval to adjourn the meeting if needed to solicit additional proxies.
Special shareholder meeting scheduled for Oct. 14, 2026
Annovis Bio will hold a special shareholder meeting in a telephonic virtual format on Oct. 14, 2026.
Shareholders will vote on increasing authorized common shares to 140,000,000 from 70,000,000.
The meeting will also consider increasing authorized preferred shares to 10,000,000 from 2,000,000.
